Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Nordlinger

Showing results (181-190 of 197) with videos related to

Pageof 20
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative GroupU Vanhoefer, P Rougier, H Wilke, et al.
British Journal of Cancer|March 18, 2004
Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastasesM Karoui, C Tresallet, C Julie, et al.
Oncogene|August 30, 2001
No evidence of somatic FGFR3 mutation in various types of carcinomaM Karoui, H Hofmann-Radvanyi, U Zimmermann, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 15, 2015
Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohortO Colussi, T Voron, A Pozet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2005
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986C-H Köhne, E van Cutsem, J Wils, et al.
Tumori|July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative GroupJ Wils, T Sahmoud, A Sobrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2006
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005E Van Cutsem, M Dicato, N Arber, et al.
Annales De Pathologie|November 28, 2006
[Recommendations for the management of gastro-intestinal stromal tumors]A Le Cesne, B Landi, S Bonvalot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2009
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008C Verslype, E Van Cutsem, M Dicato, et al.
Gastroenterologie Clinique Et Biologique|August 3, 1999
[What can be done for patients with digestive cancer in 1999? Guidelines of the French Foundation of Digestive Cancerology (2nd part)]J C Barbare, L Bedenne, O Bouché, et al.
Pageof 20

Showing results (181-190 of 197) with videos related to

Sort By:
Pageof 20
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2000
Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative GroupU Vanhoefer, P Rougier, H Wilke, et al.
British Journal of Cancer|March 18, 2004
Loss of heterozygosity on 10q and mutational status of PTEN and BMPR1A in colorectal primary tumours and metastasesM Karoui, C Tresallet, C Julie, et al.
Oncogene|August 30, 2001
No evidence of somatic FGFR3 mutation in various types of carcinomaM Karoui, H Hofmann-Radvanyi, U Zimmermann, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 15, 2015
Prognostic score for recurrence after Whipple's pancreaticoduodenectomy for ampullary carcinomas; results of an AGEO retrospective multicenter cohortO Colussi, T Voron, A Pozet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2005
Phase III study of weekly high-dose infusional fluorouracil plus folinic acid with or without irinotecan in patients with metastatic colorectal cancer: European Organisation for Research and Treatment of Cancer Gastrointestinal Group Study 40986C-H Köhne, E van Cutsem, J Wils, et al.
Tumori|July 25, 1998
Evaluation of clinical efficacy of new medical treatments in advanced colorectal cancer. Results of a workshop organized by the EORTC GITCCG. European Organization for Research and Treatment of Cancer. Gastrointestinal Tract Cancer Cooperative GroupJ Wils, T Sahmoud, A Sobrero, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2006
The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. Current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005E Van Cutsem, M Dicato, N Arber, et al.
Annales De Pathologie|November 28, 2006
[Recommendations for the management of gastro-intestinal stromal tumors]A Le Cesne, B Landi, S Bonvalot, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 6, 2009
The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 10th World Congress on Gastrointestinal Cancer, Barcelona, 2008C Verslype, E Van Cutsem, M Dicato, et al.
Gastroenterologie Clinique Et Biologique|August 3, 1999
[What can be done for patients with digestive cancer in 1999? Guidelines of the French Foundation of Digestive Cancerology (2nd part)]J C Barbare, L Bedenne, O Bouché, et al.
Pageof 20